Rhenman & Partners Asset Management AB - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,888,500
-14.5%
50,0000.0%0.20%
-14.7%
Q3 2022$2,210,000
+19.4%
50,0000.0%0.23%
+10.0%
Q2 2022$1,851,000
-29.6%
50,000
-29.6%
0.21%
-18.9%
Q1 2022$2,630,000
+14.8%
71,000
-5.3%
0.26%
+70.4%
Q4 2021$2,291,000
-8.9%
75,0000.0%0.15%
-14.1%
Q3 2021$2,516,000
-15.9%
75,0000.0%0.18%
-12.8%
Q2 2021$2,992,000
-11.3%
75,0000.0%0.20%
-13.6%
Q1 2021$3,372,000
+30.1%
75,000
+17.2%
0.24%
-54.4%
Q1 2016$2,592,000
-37.5%
64,000
-4.5%
0.52%
-17.9%
Q4 2015$4,149,00067,0000.63%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bellevue Group AG 9,463,400$418,566,0006.01%
Tweedy, Browne Co LLC 2,722,988$120,438,0005.30%
BVF INC/IL 2,872,953$127,071,0005.25%
Sicart Associates LLC 253,976$11,233,0003.98%
Parkman Healthcare Partners LLC 241,945$10,701,0003.04%
Camber Capital Management LP 1,925,000$85,143,0002.61%
Privium Fund Management B.V. 148,807$6,589,0002.39%
SECTOR GAMMA AS 164,223$7,264,0001.87%
HANSEATIC MANAGEMENT SERVICES INC 10,993$486,0001.31%
BRANDYWINE MANAGERS, LLC 8,460$374,0001.23%
View complete list of IONIS PHARMACEUTICALS INC shareholders